Oragenics
OGEN
Oragenics (OGEN) earnings history
Most recent quarter
- Fiscal period
- Q3 2022
- Period end
- Sep 30, 2022
- EPS actual
- −$54.00
- EPS estimate
- −$90.00
- EPS surprise
- +40.00%
- Revenue surprise
- +0.00%
- Revenue
- $100,000.00
- Revenue estimate
- $0.00
- Reported
- Nov 14, 2022
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2022 | Nov 14, 2022 | −$90.00 | −$54.00 | +40.00% | $100,000.00 | — |
| Q2 2022 | Aug 9, 2022 | −$72.00 | −$54.00 | +25.00% | $0.00 | — |
| Q1 2022 | May 13, 2022 | −$36.00 | −$90.00 | −150.00% | $0.00 | — |
| Q3 2021 | Nov 15, 2021 | −$72.00 | −$72.00 | +0.00% | $0.00 | — |
| Q2 2021 | Aug 16, 2021 | −$72.00 | −$54.00 | +25.00% | $0.00 | — |
| Q3 2020 | Nov 10, 2020 | −$126.00 | −$144.00 | −14.29% | $0.00 | — |
| Q2 2020 | Aug 14, 2020 | −$162.00 | −$432.00 | −166.67% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Oragenics (OGEN) last report earnings?
Oragenics last reported on Nov 14, 2022, covering fiscal Q3 2022.
Did OGEN beat earnings estimates?
Yes. Oragenics reported EPS of −$54.00 for Q3 2022 against a −$90.00 estimate — a 40.00% beat.
How much revenue did OGEN report last quarter?
Oragenics reported $100,000.00 in revenue for Q3 2022.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.